nach oben

Erschienen in:

01.10.2013 | Original Article

Pelvic floor muscle strength and urinary incontinence in hyperandrogenic women with polycystic ovary syndrome

verfasst von: Flávia Ignácio Antônio, Kari Bo, Rui Alberto Ferriani, Marcos Felipe Silva de Sá, Ana Carolina Japur de Sá Rosa e Silva, Cristine Homsi Jorge Ferreira

Erschienen in: International Urogynecology Journal | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Hyperandrogenism in women with polycystic ovary syndrome (PCOS) could increase muscle mass and thereby pelvic floor muscle (PFM) strength, reducing the risk of urinary incontinence (UI). The aim of the present study was to assess PFM strength and UI among hyperandrogenic women with PCOS and a control group for comparison.

Methods

This is an observational, cross-sectional, case–control study. Seventy-nine women, aged 18 to 40 years with a mean body mass index (BMI) of 23.4 kg/cm² were recruited at the University Hospital: PCOS (n = 36) and control group for comparison (n = 43). All PCOS women had clinical and/or laboratory hyperandrogenism (> 80 ng/dL) and control women had regular menstrual cycles. PFM strength was assessed by vaginal manometry. The International Consultation on Incontinence Questionnaire of Urinary Incontinence Short Form (ICIQ-UI SF) was used to assess UI. Descriptive analysis, analysis of variance (ANOVA) and Fisher’s exact test were used for statistical analyses.

Results

There was no statistically significant difference in mean PFM strength between the PCOS and the control group: 2.7 cm H₂O (95 % CI −6.2–11.6) p = 0.55. The prevalence of UI was 18.6 % in the control group compared with 0 % in the PCOS group p < 0.01.

Conclusions

Women with PCOS showed absence of UI, but PFM strength did not differ from the control group.

Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745–2749PubMedCrossRef

Sinha-Hikim I, Roth SM, Lee MI, Bhasin S (2003) Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab 285:197–205

Bhasin S, Calof OM, Storer TW, Lee ML, Mazer NA, Jasuja R, Montori VM, Gao W, Dalton JT (2006) Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab 2:146–159PubMedCrossRef

Douchi T, Yamamoto S, Oki T, Maruta K, Kuwahata R, Nagata Y (1999) Serum androgen levels and muscle mass in women with polycystic ovary syndrome. Obstet Gynecol 94:337–340PubMedCrossRef

Nnodim JO (1999) Quantitative study of the effects of denervation and castration on the levator ani muscle of the rat. Anat Rec 1:324–333CrossRef

Nnodim JO (2001) Testosterone mediates satellite cell activation in denervated rat levator ani muscle. Anat Rec 1:19–24CrossRef

The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2003) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47CrossRef

Cunningham SK, Loughlin T, Culliton M, McKenna TJ (1985) The role of sex steroids and sex hormone binding globulin in hirsutism and/or oligomenorrhoea in obese and normal weight women. Ir Med J 78:208–212PubMed

Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P (2004) ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn 23:322–330PubMedCrossRef

10.

Tamanini JT, Dambros M, D’Ancona CA, Palma PC, Rodrigues Netto N Jr (2004) Validation of the “international consultation on incontinence questionnaire-Short form” (ICIQ-SF) for Portuguese. Rev Saude Publica 38:438–444PubMedCrossRef

11.

Klovning A, Avery K, Sandvik H, Hunskaar S (2009) Comparison of Two questionnaires for assessing the severity of urinary incontinence: the ICIQ-UI SF versus the incontinence severity index. Neurourol Urodyn 28:411–415PubMedCrossRef

12.

Messelink B, Benson T, Berghmans B, Bø K, Corcos J, Fowler C, Laycock J, Lim PH, van Lunsen R, Nijeholt GL, Pemberton J, Wang A, Watier A, Van Kerrebroeck P (2005) Standardisation of terminology of pelvic floor muscle function and dysfunction: report from the pelvic floor clinical assessment group of the International Continence Society. Neurourol Urodyn 24:374–380PubMedCrossRef

13.

Laycock J (1994) Clinical evaluation of pelvic floor. In: Schussler B, Laycock J, Norton P, Stanton S (eds) Pelvic floor re-education. Springer, London, pp 42–48

14.

Bo K, Sherburn M (2005) Evaluation of female pelvic-floor muscle function and strength. Phys Ther 85:269–282PubMed

15.

Hundley AF, Wu JM, Visco AG (2005) A comparison of perineometer to brink score for assessment of pelvic floor muscle strength. Am J Obstet Gynecol 192:1583–1591PubMedCrossRef

16.

Ferreira CH, Barbosa PB, de Oliveira SF, Antônio FI, Franco MM, Bø K (2011) Inter-rater reliability study of the modified Oxford grading scale and the Peritron manometer. Physiotherapy 97:132–138PubMedCrossRef

17.

Bo K, Kvarstein B, Hagen RR, Larsen S (1990) Pelvic floor muscle exercise for the treatment of female stress urinary-incontinence. II. Validity of vaginal pressure measurements of pelvic floor muscle strength and the necessity of supplementary methods for control of correct contraction. Neurourol Urodyn 9:479–487CrossRef

18.

Montgomery DC (2000) Design and analysis of experiments, 5th edn. Wiley, New York

19.

Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan AR, Wolfe RR, Ferrando A (1995) Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 269:E820–E826PubMed

20.

Brodsky IG, Balagopal P, Nair KS (1996) Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men—a clinical research center study. J Clin Endocrinol Metab 81:3469–3475PubMedCrossRef

21.

Douchi T, Yoshimitsu N, Nagata Y (2001) Relationships among serum testosterone levels, body fat and muscle mass distribution in women with polycystic ovary syndrome. Endocr J 48:685–689PubMedCrossRef

22.

DeLancey JO (1994) Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol 170:1713–1730PubMed

23.

DeLancey JO, Kearney R, Chou Q, Speights S, Binno S (2003) The appearance of levatorani muscle abnormalities in magnetic resonance images after vaginal delivery. Obstet Gynecol 101:46–53PubMedCrossRef

24.

Mammadov R, Simsir A, Tuglu I, Evren V, Gurer E, Özyurt C (2011) The effect of testosterone treatment on urodynamic findings and histopathomorphology of pelvic floor muscles in female rats with experimentally induced stress urinary incontinence. Int Urol Nephrol 43:1003–1008PubMedCrossRef

25.

Montezuma T, Antônio FI, Rosa e Silva AC, de Sá MF, Ferriani RA, Ferreira CH (2011) Assessment of symptoms of urinary incontinence in women with polycystic ovary syndrome. Clinics 66:1911–1915PubMedCrossRef

26.

Jung J, Ahn HK, Huh Y (2012) Clinical and functional anatomy of the urethral sphincter. Int Neurourol J 16:102–106PubMedCrossRef

27.

Bo K, Berghmans B, Morkved S, Van Kampen M (2007) Evidence-based physical therapy for the pelvic floor: bridging science and clinical practice, 1st edn. Elsevier, Philadelphia, pp 164–167

28.

Thom D (1998) Variations in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc 46:473–480PubMed

29.

Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, Spino C, Whitehead WE, Wu J, Brody DJ (2008) Pelvic floor disorders network. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 300:1311–1316PubMedCrossRef

30.

Milsom I, Altman D, Lapitan MC, Nelson R, Sillén U, Thom D (2009) Epidemiology of urinary (UI) and faecal (FI) incontinence and pelvic organ prolapse (POP). ICS Publications, Bristol

Titel: Pelvic floor muscle strength and urinary incontinence in hyperandrogenic women with polycystic ovary syndrome
verfasst von: Flávia Ignácio Antônio
Kari Bo
Rui Alberto Ferriani
Marcos Felipe Silva de Sá
Ana Carolina Japur de Sá Rosa e Silva
Cristine Homsi Jorge Ferreira
Publikationsdatum: 01.10.2013
Verlag: Springer London
Erschienen in: International Urogynecology Journal / Ausgabe 10/2013
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-013-2095-x

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Pelvic floor muscle strength and urinary incontinence in hyperandrogenic women with polycystic ovary syndrome

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2013

The cube pessary: an underestimated treatment option for pelvic organ prolapse? Subjective 1-year outcomes

Design and development of a novel intra-vaginal pressure sensor

Tissue engineering: creation of an autogenic collagenous neoligament for cure of urinary stress incontinence. Reply to Petros

Interobserver variability when employing the IUGA/ICS classification system for complications related to prostheses and grafts in female pelvic floor surgery

Surgical treatment of pelvic organ prolapse: a historical review with emphasis on the anterior compartment

Urinary nerve growth factor: a biomarker of detrusor overactivity? A systematic review

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie